Company Information
CIN
Status
Date of Incorporation
10 March 1989
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
2,770,560,000
Authorised Capital
3,200,000,000
Directors
Venkatanarasa Reddy Attunuri
Director/Designated Partner
about 2 years ago
about 2 years ago
Govindaraju Bhavani
Director/Designated Partner
about 2 years ago
about 2 years ago
Bhavesh Bansidhar Pujara
Director/Designated Partner
over 2 years ago
over 2 years ago
Parthasaradhi Reddy Bandi
Director/Designated Partner
over 2 years ago
over 2 years ago
Rathnakar Reddy Kura
Director/Designated Partner
over 2 years ago
over 2 years ago
Bandi Vamsikrishna
Director/Designated Partner
over 2 years ago
over 2 years ago
Srinivas Reddy Male
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Kalavathi Bandi
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Rajasekhara Reddy
Nominee
almost 10 years ago
almost 10 years ago
Mohana Reddy Chilukuri
Director/Designated Partner
over 19 years ago
over 19 years ago
Past Directors
Karuppannan Ganesh
Cfo(kmp)
over 6 years ago
over 6 years ago
Srinivas Vengala
Company Secretary
over 7 years ago
over 7 years ago
Ravi Kumar Upputhalla
Company Secretary
over 7 years ago
over 7 years ago
Gopal Reddy Annareddy
Additional Director
about 10 years ago
about 10 years ago
Bollareddy Reddy Narasa
Director
about 26 years ago
about 26 years ago
Patents
Formula (I) The invention relates to C 3 novel triterpenone with C 28 reverse amide derivatives related compounds and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
The invention relates to a process for producing tablet compositions of etravirine comprising solid dispersion of etravirine, hydroxylpropyl methyl cellulose and optionally one or more pharmaceutically acceptable excipients, wherein the solid dispersion doesn"t contain microcrystalline cellulose.
...
ABSTRACT:
Title: “Process for preparation of ((3R,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one”
The present invention provides a process for preparation of deutetrabenazine using tetrabenazine as starting material.
"STABLE BILAYER TABLET COMPOSITIONS"
ABSTRACT:
The invention relates to stable bilayer tablet compositions comprising empagliflozin, linagliptin and pharmaceutically acceptable excipients which show no incompatibilities and the compositions having good stability and superior dissolution profile.
...
DISPERSIBLE TABLET COMPOSITIONS OF DOLUTEGRAVIR
ABSTRACT
The present invention relates to dispersible tablet composition of dolutegravir sodium and one or more pharmaceutically acceptable excipients and process for preparation of such compositions.
TABLET COMPOSITIONS COMPRISING BICTEGRAVIR, TENOFOVIR ALAFENAMIDE AND EMTRICITABINE
ABSTRACT
The present invention relates to monolayer tablet compositions comprising bictegravir or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, emtricitabine or...
STABLE ORAL LIQUID COMPOSITIONS OF ENALAPRIL
ABSTRACT
The present invention relates to pharmaceutical compositions of enalapril, particularly stable oral liquid compositions comprising enalapril, one or more buffering agents and at least one pharmaceutically acceptable excipient.
The present invention relates to pharmaceutical compositions of sacubitril and valsartan and a process for the preparation thereof. Particularly, the present invention relates to stable non-aqueous based tablet composition of sacubitril and valsartan and a process for the preparation thereof.
The present invention relates to process for their preparation of Lifitegrast and its intermediate
The present invention relates to a process for preparing Midostaurin.
LIQUID PHARMACEUTICAL COMPOSITION COMPRISING SODIUM PICOSULFATE, MAGNESIUM OXIDE AND CITRIC ACID
ABSTRACT
Described herein is a stable oral liquid pharmaceutical product comprising sodium picosulfate, magnesium oxide and citric acid. Particularly, sodium picosulfate is physically separated from magnesium oxide...
The present invention is directed to taste masked oral liquid suspension composition comprising resinate complex of solifenacin or a pharmaceutically acceptable salt thereof prepared by admixing palatable ingredients of differential polarities.
The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, n, and ring (II) are as defined in formula (I). The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful fo...
TABLET COMPOSITIONS OF ETRAVIRINE
ABSTRACT
The invention relates to tablet compositions of etravirine comprising hydroxypropyl methyl cellulose having a methoxy content of 25.0 - 32.0% (w/w), a hydroxypropoxy content of 22.0 - 27.0% (w/w) and a viscosity of 10.0 - 20.0 cps and process for preparing such tablet com...
The present invention relates to pharmaceutical compositions of lopinavir and ritonavir and process for preparation thereof. Particularly, the present invention relates to pharmaceutical capsule compositions of lopinavir and ritonavir and process for preparation thereof.
The present invention relates to pharmaceutical stable oral liquid compositions of naproxen and one or more pharmaceutically acceptable excipients.
The present invention relates to process for preparing sartan drugs including intermediates thereof, which avoids formation of Nitrosoamine impurities.
The present invention relates to the efficient solid-phase synthesis of Aviptadil represented by Formula-I. The present invention relates to an efficient process for the preparation of Aviptadil by sequential coupling employing solid phase approach. It involves sequential coupling of protected amino acids to prepare...
The present invention relates to a process for preparation of Doravirine and its intermediate compounds.
TITLE: “AN IMPROVED PROCESS FOR PREPARATION OF ENCORAFENIB”
The present invention relates to an improved process for the preparation of Encorafenib represented by Formula (I). The present invention relates to cost-effective and eco-friendly process for preparation of Encorafenib.
The present invention relates to novel triterpenone derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. The invention also relates to novel triterpenone derivatives, related compounds, and pharmaceutical compositions useful for the thera...
The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and ring are as defined herein. The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeuti...
The present invention relates to a process for preparation of Pitolisant and its pharmaceutically acceptable salt thereof and its intermediates.
The invention relates to a stable pharmaceutical liquid composition comprising lisinopril or its pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients and process of its preparation.
The present invention relates to an improved process for the preparation of Voxelotor and its key intermediate (2-(1-Isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol
The present invention relates to Amorphous Lenacapavir Sodium solid dispersion and its process for preparation thereof. The amorphous Lenacapavir Sodium solid dispersions of the present application can be reproduced easily and is amenable for processing into a dosage form.
The present invention relates to an improved process for preparation of Cabozantinib S-malate, which comprises of reacting 4-[(6,7-dimethoxy-4-quinolyl)oxy]aniline compound of formula IV and 1-[(4-fluorophenyl)carbamoyl]cyclopropane carboxylic acid compound of formula-V in presence of Propanephosphonic acid anhydrid...
The present invention relates to Amorphous solid dispersion of Acalabrutinib maleate with a suitable pharmaceutically acceptable excipient selected from a group consisting of hydroxyl propyl cellulose (HPC), hydroxyl propyl methyl cellulose (HPMC), hydroxyl propyl methyl cellulose – acetate succinate (HPMC-AS), Povi...
The present invention relates to a process for preparation of Pacritinib, its pharmaceutically acceptable salts and intermediates thereof.
The present invention relates to a process for preparing crystalline form of Oseltamivir free base Form H.
The present invention is directed to an improved, industrially viable, cost-effective process for the industrial manufacturing of enantiomerically pure (S,S)-2,8-diazabicyclo[4.3.0]nonane of Formula I which is used as an intermediate in the preparation of Moxifloxacin.
The present invention relates to process for the preparation of Ponesimod and its intermediate thereof
The present invention relates to process for preparation of Trilaciclib or its pharmaceutical acceptable salts, which comprises condensing Chloro-7’,8’-dihydro-6’H-spiro[cyclohexane-1,9’-pyrazino[1’,2’:1,5]pyrrolo[2,3-d]pyrimidin]-6’-one compound of formula IV with 5-(4-Methylpiperazine-1-yl)pyridine-2-amine compoun...
The present invention relates to a process for preparation of oxygen linked pyrimidine derivative, useful as anti-proliferative agent (Pacritinib), its pharmaceutically acceptable salts and intermediates thereof.
The present invention relates to a process for the preparation of Lenacapavir or its
pharmaceutically acceptable salts, wherein involves propylphosphonic anhydride as
amide coupling reagent.
TITLE: “An improved process for preparation of Zastaprazan”
The present invention relates to an improved process for preparation of Zastaprazan or its pharmaceutically acceptable salts, which comprises: a) reaction of methyl 5,6-diaminonicotinate and 3-bromobutan-2-one to obtain methyl 8-amino-2,3-dimethyl imidazo[...
TITLE: “An improved process for preparation of Elacestrant or its dihydrochloride salt”
The present invention relates to an improved process for preparation of Elacestrant or its pharmaceutically acceptable salts, which comprises: a) reacting the compound of Formula II
with the compound of Formula III to obtain co...
Registered Trademarks
[Class : 5] Pharmaceutical And Medicinal
Preparations
[Class : 5] Pharmaceutical And Medicinal
Preparations
[Class : 5] Pharmaceutical And Medicinal
Preparations
View +225 more Brands for Hetero Labs Limited.
Charges
09 June 2018
Mufg Bank Ltd
385 Crore
10 June 2016
Export-import Bank Of India
76 Crore
19 December 2013
Export-import Bank Of India
120 Crore
17 January 2008
Andhra Bank
3,666 Crore
10 October 2004
State Bank Of India
4,248 Crore
29 September 2006
Bank Of India
2 Crore
10 March 2004
Bank Of India
1 Crore
21 January 2014
Bank Of India
212 Crore
06 October 2003
Bank Of India
1 Crore
13 March 2003
Bank Of India
1 Crore
24 July 1998
Andhra Bank
315 Crore
10 October 2003
State Bank Of Hyderabad
97 Crore
25 August 2004
Andhra Bank
15 Crore
15 April 2004
Andhra Bank
3 Crore
24 June 2008
State Bank Of Mysore
30 Crore
20 August 2010
Andhra Bank
86 Crore
26 March 2011
Andhra Bank
50 Crore
27 April 1998
Andhra Bank
2 Crore
07 December 2010
Andhra Bank
50 Crore
18 July 2005
Andhra Bank
2 Crore
14 March 2009
State Bank Of Hyderabad
490 Crore
26 March 2011
Andhra Bank
1,642 Crore
28 October 2013
Dbs Bank Limited
125 Crore
27 March 2013
State Bank Of India
418 Crore
16 March 2011
Export-import Bank Of India
100 Crore
14 September 2011
State Bank Of Mysore
25 Crore
16 November 2010
State Bank Of Hyderbad
50 Crore
28 September 2010
State Bank Of India
50 Crore
21 October 2008
Bank Of India Limited
80 Crore
25 January 2007
State Bank Of Indore
20 Crore
02 December 2008
Andhra Bank
25 Crore
09 July 2008
Andhra Bank
15 Crore
19 October 2006
Andhra Bank
6 Crore
13 December 1999
Industrial Development Bank Of India
4 Crore
04 July 2002
Bank Of Bahrain & Kuwait Bsc
7 Crore
21 March 1990
A.p. State Financial Corporation
38 Lak
21 March 1990
A.p. State Financial Corporation
2 Lak
15 August 2021
Mahindra And Mahindra Financial Services Limited
1 Crore
28 June 2021
Hdfc Bank Limited
13 Lak
31 March 2021
Hdfc Bank Limited
13 Lak
24 March 2021
Axis Bank Limited
315 Crore
06 March 2021
Hdfc Bank Limited
15 Lak
03 March 2021
Hdfc Bank Limited
12 Lak
03 March 2021
Hdfc Bank Limited
12 Lak
12 February 2021
Hdfc Bank Limited
11 Lak
11 February 2021
Hdfc Bank Limited
11 Lak
08 February 2021
Hdfc Bank Limited
9 Lak
21 January 2021
Hdfc Bank Limited
14 Lak
12 January 2021
Hdfc Bank Limited
18 Lak
08 January 2021
Mahindra And Mahindra Financial Services Limited
4 Crore
07 January 2021
Hdfc Bank Limited
51 Lak
30 December 2020
Hdfc Bank Limited
12 Lak
19 December 2020
Hdfc Bank Limited
7 Lak
26 October 2020
Axis Bank Limited
200 Crore
21 September 2020
Idbi Trusteeship Services Limited
4,346 Crore
18 August 2020
Mahindra And Mahindra Financial Services Limited
2 Crore
26 June 2020
State Bank Of India
48 Crore
30 March 2020
Bank Of Baroda
492 Crore
07 January 2020
Hdfc Bank Limited
9 Lak
18 November 2019
Union Bank Of India
365 Crore
16 November 2023
Others
0
15 November 2023
Others
0
16 November 2023
Others
0
13 October 2023
State Bank Of India
0
25 October 2023
Others
0
06 October 2023
Others
0
27 September 2023
Others
0
30 September 2023
Others
0
30 September 2023
Others
0
31 August 2023
Others
0
26 September 2023
Others
0
12 August 2023
Others
0
05 July 2023
Others
0
14 July 2023
Others
0
30 June 2023
Others
0
27 June 2023
Others
0
24 May 2023
Others
0
31 March 2023
Others
0
11 May 2023
Others
0
17 March 2023
Others
0
21 January 2023
Others
0
25 November 2022
Others
0
29 November 2022
Others
0
25 August 2022
Others
0
01 November 2022
Others
0
30 October 2022
Others
0
21 October 2022
Others
0
18 October 2022
Others
0
27 September 2022
Others
0
02 August 2022
Others
0
27 September 2022
Others
0
25 August 2022
Others
0
23 August 2022
Others
0
03 October 2022
State Bank Of India
0
30 July 2022
Others
0
15 July 2022
Axis Bank Limited
0
30 December 2020
Hdfc Bank Limited
0
26 June 2020
State Bank Of India
0
08 March 2022
Others
0
10 October 2004
State Bank Of India
0
15 August 2021
Others
0
08 December 2021
Others
0
25 November 2021
Others
0
16 November 2021
Others
0
26 November 2021
State Bank Of India
0
21 September 2020
Idbi Trusteeship Services Limited
0
07 January 2021
Hdfc Bank Limited
0
12 January 2021
Hdfc Bank Limited
0
21 January 2021
Hdfc Bank Limited
0
08 January 2021
Others
0
12 February 2021
Hdfc Bank Limited
0
08 February 2021
Hdfc Bank Limited
0
11 February 2021
Hdfc Bank Limited
0
24 March 2021
Axis Bank Limited
0
03 March 2021
Hdfc Bank Limited
0
06 March 2021
Hdfc Bank Limited
0
30 December 2020
Hdfc Bank Limited
0
03 March 2021
Hdfc Bank Limited
0
31 March 2021
Hdfc Bank Limited
0
28 June 2021
Hdfc Bank Limited
0
19 December 2020
Hdfc Bank Limited
0
26 October 2020
Axis Bank Limited
0
18 August 2020
Others
0
30 March 2020
Others
0
07 January 2020
Hdfc Bank Limited
0
18 November 2019
Others
0
09 June 2018
Others
0
18 July 2005
Andhra Bank
0
26 March 2011
Others
0
14 March 2009
Others
0
19 October 2006
Andhra Bank
0
25 January 2007
State Bank Of Indore
0
26 March 2011
Andhra Bank
0
04 July 2002
Bank Of Bahrain & Kuwait Bsc
0
27 April 1998
Andhra Bank
0
02 December 2008
Andhra Bank
0
10 March 2004
Bank Of India
0
06 October 2003
Bank Of India
0
13 March 2003
Bank Of India
0
13 December 1999
Industrial Development Bank Of India
0
21 March 1990
A.p. State Financial Corporation
0
10 June 2016
Others
0
07 December 2010
Andhra Bank
0
19 December 2013
Export-import Bank Of India
0
28 October 2013
Dbs Bank Limited
0
20 August 2010
Andhra Bank
0
29 September 2006
Bank Of India
0
10 October 2003
State Bank Of Hyderabad
0
25 August 2004
Andhra Bank
0
15 April 2004
Andhra Bank
0
21 March 1990
A.p. State Financial Corporation
0
21 January 2014
Bank Of India
0
27 March 2013
State Bank Of India
0
14 September 2011
State Bank Of Mysore
0
24 July 1998
Andhra Bank
0
16 March 2011
Export-import Bank Of India
0
16 November 2010
State Bank Of Hyderbad
0
28 September 2010
State Bank Of India
0
21 October 2008
Bank Of India Limited
0
09 July 2008
Andhra Bank
0
24 June 2008
State Bank Of Mysore
0
17 January 2008
Others
0
12 December 2023
Others
0
16 November 2023
Others
0
15 November 2023
Others
0
16 November 2023
Others
0
13 October 2023
State Bank Of India
0
25 October 2023
Others
0
06 October 2023
Others
0
27 September 2023
Others
0
30 September 2023
Others
0
30 September 2023
Others
0
31 August 2023
Others
0
26 September 2023
Others
0
12 August 2023
Others
0
05 July 2023
Others
0
14 July 2023
Others
0
30 June 2023
Others
0
27 June 2023
Others
0
24 May 2023
Others
0
31 March 2023
Others
0
11 May 2023
Others
0
17 March 2023
Others
0
21 January 2023
Others
0
25 November 2022
Others
0
29 November 2022
Others
0
25 August 2022
Others
0
01 November 2022
Others
0
30 October 2022
Others
0
21 October 2022
Others
0
18 October 2022
Others
0
27 September 2022
Others
0
02 August 2022
Others
0
27 September 2022
Others
0
25 August 2022
Others
0
23 August 2022
Others
0
03 October 2022
State Bank Of India
0
30 July 2022
Others
0
15 July 2022
Axis Bank Limited
0
30 December 2020
Hdfc Bank Limited
0
26 June 2020
State Bank Of India
0
08 March 2022
Others
0
10 October 2004
State Bank Of India
0
15 August 2021
Others
0
08 December 2021
Others
0
25 November 2021
Others
0
16 November 2021
Others
0
26 November 2021
State Bank Of India
0
21 September 2020
Idbi Trusteeship Services Limited
0
07 January 2021
Hdfc Bank Limited
0
12 January 2021
Hdfc Bank Limited
0
21 January 2021
Hdfc Bank Limited
0
08 January 2021
Others
0
12 February 2021
Hdfc Bank Limited
0
08 February 2021
Hdfc Bank Limited
0
11 February 2021
Hdfc Bank Limited
0
24 March 2021
Axis Bank Limited
0
03 March 2021
Hdfc Bank Limited
0
06 March 2021
Hdfc Bank Limited
0
30 December 2020
Hdfc Bank Limited
0
03 March 2021
Hdfc Bank Limited
0
31 March 2021
Hdfc Bank Limited
0
28 June 2021
Hdfc Bank Limited
0
19 December 2020
Hdfc Bank Limited
0
26 October 2020
Axis Bank Limited
0
18 August 2020
Others
0
30 March 2020
Others
0
07 January 2020
Hdfc Bank Limited
0
18 November 2019
Others
0
09 June 2018
Others
0
18 July 2005
Andhra Bank
0
26 March 2011
Others
0
14 March 2009
Others
0
19 October 2006
Andhra Bank
0
25 January 2007
State Bank Of Indore
0
26 March 2011
Andhra Bank
0
04 July 2002
Bank Of Bahrain & Kuwait Bsc
0
27 April 1998
Andhra Bank
0
02 December 2008
Andhra Bank
0
10 March 2004
Bank Of India
0
06 October 2003
Bank Of India
0
13 March 2003
Bank Of India
0
13 December 1999
Industrial Development Bank Of India
0
21 March 1990
A.p. State Financial Corporation
0
10 June 2016
Others
0
07 December 2010
Andhra Bank
0
19 December 2013
Export-import Bank Of India
0
28 October 2013
Dbs Bank Limited
0
20 August 2010
Andhra Bank
0
29 September 2006
Bank Of India
0
10 October 2003
State Bank Of Hyderabad
0
25 August 2004
Andhra Bank
0
15 April 2004
Andhra Bank
0
21 March 1990
A.p. State Financial Corporation
0
21 January 2014
Bank Of India
0
27 March 2013
State Bank Of India
0
14 September 2011
State Bank Of Mysore
0
24 July 1998
Andhra Bank
0
16 March 2011
Export-import Bank Of India
0
16 November 2010
State Bank Of Hyderbad
0
28 September 2010
State Bank Of India
0
21 October 2008
Bank Of India Limited
0
09 July 2008
Andhra Bank
0
24 June 2008
State Bank Of Mysore
0
17 January 2008
Others
0
Documents
Form DPT-3-04012021_signed
Form DIR-12-25122020_signed
Evidence of cessation;-24122020
Optional Attachment-(1)-23112020
Particulars of all joint charge holders;-23112020
Form CHG-1-23112020_signed
Instrument(s) of creation or modification of charge;-23112020
CERTIFICATE OF REGISTRATION OF CHARGE-20201123
Form CHG-1-19112020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201119
Optional Attachment-(1)-18112020
Instrument(s) of creation or modification of charge;-18112020
Form CHG-1-07112020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20201107
Instrument(s) of creation or modification of charge;-06112020
Particulars of all joint charge holders;-06112020
Form CHG-1-23072020_signed
Optional Attachment-(1)-23072020
Instrument(s) of creation or modification of charge;-23072020
CERTIFICATE OF REGISTRATION OF CHARGE-20200723
Form MSME FORM I-30042020_signed
Optional Attachment-(1)-31032020
Instrument(s) of creation or modification of charge;-31032020
Form CHG-1-31032020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20200331
Form DPT-3-20022020-signed
Optional Attachment-(1)-03022020
Instrument(s) of creation or modification of charge;-03022020
Form CHG-1-03022020_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20200203
